AQR Capital Management
TIL icon

AQR Capital Management’s Instil Bio TIL Stock Holding History

AQR Capital Management’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,946
Closed -$25.7K – 2281
2023
Q1 		$25.7K Buy
1,946
+1,321
+211% +$19.5K ﹤0.01% 2150
2022
Q4 		$7.88K Buy
+625
New +$30.9K ﹤0.01% 2187

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AQR Capital Management's TIL Position: Q2 2023 in Review

AQR Capital Management sold out of Instil Bio (TIL) in Q2 2023, closing a stake of 1,946 shares — an estimated $25.7K sold.

AQR Capital Management first reported a position in TIL in Q4 2022 and held it in 2 quarters. The position peaked at $25.7K in Q1 2023. 62 funds tracked by Wall St. Rank hold TIL as of Q2 2023.

  • AQR Capital Management reported no remaining Instil Bio position as of Q2 2023 after selling out during the quarter.
  • AQR Capital Management sold 1,946 Instil Bio shares in Q2 2023, an estimated $25.7K.
  • AQR Capital Management first reported a position in Instil Bio in Q4 2022 and held it in 2 quarters.
  • AQR Capital Management's Instil Bio position peaked at $25.7K in Q1 2023.
  • 62 funds tracked by Wall St. Rank held Instil Bio as of Q2 2023.

Based on AQR Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.